These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1551174

  • 1. Ionic rhenocene derivatives with antitumor activity.
    Köpf-Maier P, Klapötke T.
    Cancer Chemother Pharmacol; 1992; 29(5):361-6. PubMed ID: 1551174
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation states.
    Köpf-Maier P, Klapötke T.
    J Cancer Res Clin Oncol; 1992; 118(3):216-21. PubMed ID: 1548287
    [Abstract] [Full Text] [Related]

  • 3. Ionic titanocene complexes: a new type of antitumor agent.
    Köpf-Maier P, Neuse E, Klapötke T, Köpf H.
    Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of titanocene amino acid complexes.
    Köpf-Maier P, Tornieporth-Oetting IC.
    Biometals; 1996 Jul; 9(3):267-71. PubMed ID: 8696077
    [Abstract] [Full Text] [Related]

  • 5. Antitumor properties of organometallic metallocene complexes of tin and germanium.
    Köpf-Maier P, Janiak C, Schumann H.
    J Cancer Res Clin Oncol; 1988 Jul; 114(5):502-6. PubMed ID: 3182909
    [Abstract] [Full Text] [Related]

  • 6. [Toxicity and antitumoral activity of two new complex compounds of rhenium].
    Natorkhin MI, Stukov AN, Filov VA.
    Vopr Onkol; 2002 Jul; 48(1):61-2. PubMed ID: 12101569
    [Abstract] [Full Text] [Related]

  • 7. Antitumor metallocenes: new developments and toxicologic features.
    Köpf-Maier P, Köpf H.
    Anticancer Res; 1986 Jul; 6(2):227-33. PubMed ID: 3707060
    [Abstract] [Full Text] [Related]

  • 8. Tumor inhibition by ferricenium complexes. Activity against some solid experimental tumors.
    Köpf-Maier P, Klapötke T.
    Arzneimittelforschung; 1989 Mar; 39(3):369-71. PubMed ID: 2757661
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies of rhenium carboxylates as antitumor agents. Part II. Antitumor studies of bis (mu-propionato) diaquotetrabromodirhenium (III) in tumor-bearing mice.
    Eastland GW, Yang G, Thompson T.
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):435-8. PubMed ID: 6668962
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
    Silvestru C, Socaciu C, Bara A, Haiduc I.
    Anticancer Res; 1990 Sep; 10(3):803-4. PubMed ID: 2369094
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice.
    Köpf-Maier P, Moormann A, Köpf H.
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):853-7. PubMed ID: 4043173
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of an ionic titanocene tetrachloroferrate derivative against some solid experimental tumors.
    Köpf-Maier P, Klapötke T.
    Arzneimittelforschung; 1989 Apr; 39(4):488-90. PubMed ID: 2751735
    [Abstract] [Full Text] [Related]

  • 19. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC, Ramos AL, Rehmann FJ, Sweeney NJ, Strohfeldt K, Tacke M, Queiroz ML.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):264-70. PubMed ID: 16513106
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.